Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids

Completed · Phase 1

Conditions studied: Dystrophinopathy, Duchenne Muscular Dystrophy, Becker's Muscular Dystrophy

In brief

The purpose of the study is to assess the safety, tolerability, and effects of L-Arginine on muscles in boys with dystrophinopathy on corticosteroids. Specifically, to see if L-arginine reduces muscle signal abnormalities on MRI done pre and post 30 days of L-arginine administration.

Key facts

Study ID
NCT01388764
Run by
Massachusetts General Hospital
People needed
7
Starts
2012-01-01
Expected to finish
2012-05-01
Last updated by the study team
2012-07-03

Who can join

Age: 7 and older, up to 11. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.